On Wednesday, Larimar Therapeutics Inc (LRMR) stock saw a modest uptick, ending the day at $7.71 which represents a slight increase of $0.29 or 3.91% from the prior close of $7.42. The stock opened at ...
Shares of Larimar Therapeutics (NASDAQ:LRMR) gained on Wednesday after Oppenheimer launched the company with an Outperform recommendation, citing the potential of its lead asset, nomlabofusp, targeted ...
Oppenheimer has initiated coverage on Larimar Therapeutics, emphasizing its lead program Nomlabofusp as a transformative therapy for Friedreich's ataxia. With a price target of $26, the company plans ...
The overall quant rating is not an average of the factor grades listed. Instead, it gives greater weight to the metrics with the strongest predictive value.
On Thursday, Larimar Therapeutics (NASDAQ:LRMR) shares received an Outperform rating from Wedbush with a price target set at $22. The biopharmaceutical company, focused on the development of ...
Fintel reports that on October 2, 2024, HC Wainwright & Co. initiated coverage of Larimar Therapeutics (NasdaqGM:LRMR) with a Buy recommendation. As of September 25, 2024, the average one-year ...